| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204252 Granulocytic ehrlichiosis is an acute, potentially fatal tick-borne infection. |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204044 Capsid protein; for the detection and prevention of viral infection |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204038 Desaturase antigen of Mycobacterium tuberculosis |
| 03/20/2001 | US6204019 Sec A2 from Streptococcus pneumoniae |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204010 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/20/2001 | US6204007 Antibodies against E-selectin |
| 03/20/2001 | US6204003 Methods for the diagnosis of feline infectious anemia |
| 03/20/2001 | US6203801 Coccidiosis polypeptide and vaccines |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203799 Cholera vaccines; deleted mutant strain |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203787 Treating tumors using implants comprising combinations of allogeneic cells |
| 03/17/2001 | CA2281913A1 A vaccine against piscirickettsia salmonis based on a recombinant 17 kd protein |
| 03/15/2001 | WO2001018845A1 Method of determining etch endpoint using principal components analysis of optical emission spectra |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018212A2 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 03/15/2001 | WO2001018208A2 Interferon induced polynucleotides and proteins encoded thereby |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018199A1 Chimaeric plant viruses with mucin peptides |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017556A1 Vaccine preparations for mucosal administration |
| 03/15/2001 | WO2001017555A2 Food grade saponins as oral adjuvants |
| 03/15/2001 | WO2001017554A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 03/15/2001 | WO2001017553A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | WO2001017551A2 Combined vaccine compositions |
| 03/15/2001 | WO2001017550A2 Vaccine against hbv and hpv |
| 03/15/2001 | WO2001017543A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 03/15/2001 | WO2001017536A2 Novel autogenous vaccines used to obtain an immune tolerance |
| 03/15/2001 | WO2000078353A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000066154A3 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/15/2001 | WO2000061610A3 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 03/15/2001 | WO1999062545A3 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943787A1 Antiviral agent, e.g. vaccine, antibody, agent that inhibits viral replication, transcription or translation, useful for preventing or treating tumors (or conditions which may become tumorous) associated with viral infections |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383980A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383213A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083227A1 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 03/14/2001 | EP1082965A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 03/14/2001 | EP1082436A2 Moraxella catarrhalis pilq proteins |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082428A2 Inhibition of viral infection and spread with viral and rhoa-derived peptides |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082411A2 Method for preparation and in vivo administration of antigen presenting cell composition |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082342A2 Vaccine for pseudomonas aeruginosa |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082135A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 03/14/2001 | EP1082134A2 Composition comprising tumor cells and extracts and method of using thereof |
| 03/14/2001 | EP1082011A2 Avian polyomavirus vaccines in psittacine birds |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | EP0584279B1 Targeted delivery of genes encoding immunogenic proteins |
| 03/14/2001 | CN1287573A Enhanced immunogen for inactivated vaccine for infection with Japanese ence phalitis Viruses and process for producing the same |
| 03/14/2001 | CN1287493A Formulation of nucleic acids and acemannan |
| 03/14/2001 | CN1063091C Functional milk for immunization |